SE9704401D0 - Matrix pellets for greasy, oily or sticky drug substances - Google Patents

Matrix pellets for greasy, oily or sticky drug substances

Info

Publication number
SE9704401D0
SE9704401D0 SE9704401A SE9704401A SE9704401D0 SE 9704401 D0 SE9704401 D0 SE 9704401D0 SE 9704401 A SE9704401 A SE 9704401A SE 9704401 A SE9704401 A SE 9704401A SE 9704401 D0 SE9704401 D0 SE 9704401D0
Authority
SE
Sweden
Prior art keywords
greasy
oily
sticky
drug substances
matrix pellets
Prior art date
Application number
SE9704401A
Other languages
English (en)
Inventor
Christer Karlsson
Per Johan Lundberg
Adam Rosinski
Malin Soederbom
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9704401A priority Critical patent/SE9704401D0/sv
Publication of SE9704401D0 publication Critical patent/SE9704401D0/sv
Priority to TW087117778A priority patent/TW570813B/zh
Priority to ARP980105800A priority patent/AR016684A1/es
Priority to ZA9810465A priority patent/ZA9810465B/xx
Priority to SK659-2000A priority patent/SK6592000A3/sk
Priority to JP2000522899A priority patent/JP2001524514A/ja
Priority to BR9814756-0A priority patent/BR9814756A/pt
Priority to NZ504354A priority patent/NZ504354A/en
Priority to CN98811637A priority patent/CN1280493A/zh
Priority to AT98957269T priority patent/ATE286382T1/de
Priority to PL98340926A priority patent/PL340926A1/xx
Priority to IL13614498A priority patent/IL136144A0/xx
Priority to PCT/SE1998/002090 priority patent/WO1999027913A1/en
Priority to EP98957269A priority patent/EP1032371B1/en
Priority to KR1020007005803A priority patent/KR20010032558A/ko
Priority to RU2000113730/14A priority patent/RU2216316C2/ru
Priority to DE69828527T priority patent/DE69828527T2/de
Priority to CA002311930A priority patent/CA2311930A1/en
Priority to US09/214,317 priority patent/US6555138B1/en
Priority to HU0004405A priority patent/HUP0004405A3/hu
Priority to IDW20000913A priority patent/ID24185A/id
Priority to AU13564/99A priority patent/AU746324B2/en
Priority to NO20002720A priority patent/NO20002720L/no
Priority to US10/385,926 priority patent/US20030175352A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
SE9704401A 1997-11-28 1997-11-28 Matrix pellets for greasy, oily or sticky drug substances SE9704401D0 (sv)

Priority Applications (24)

Application Number Priority Date Filing Date Title
SE9704401A SE9704401D0 (sv) 1997-11-28 1997-11-28 Matrix pellets for greasy, oily or sticky drug substances
TW087117778A TW570813B (en) 1997-11-28 1998-10-27 Matrix pellets for greasy, oily or sticky drug substances
ARP980105800A AR016684A1 (es) 1997-11-28 1998-11-16 Composicion seca y solida para administracion de farmacos, proceso para su preparacion y el uso de una pluralidad de perlas que contienen una matrizpolimerica para la elaboracion de dicha composicion.
ZA9810465A ZA9810465B (en) 1997-11-28 1998-11-16 Matrix pellets for greasy oily or sticky drug substances
IDW20000913A ID24185A (id) 1997-11-28 1998-11-18 Pelet matriks polietilena glikol untuk bahan obat yang berlemak, berminyak atau lengket
PL98340926A PL340926A1 (en) 1997-11-28 1998-11-18 Polyethylene glycol matrix granules for drugs in the form of fatty, oily or highly viscous substances
EP98957269A EP1032371B1 (en) 1997-11-28 1998-11-18 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
BR9814756-0A BR9814756A (pt) 1997-11-28 1998-11-18 Composição sólida seca para liberação de droga, processo para a preparação da mesma, uso de um grande número de pequenas esferas que contêm uma matriz polimérica composta de um polietileno glicol ou de uma mistura de polietileno glicóis
NZ504354A NZ504354A (en) 1997-11-28 1998-11-18 Polyethylene glycol matrix pellets for fast release of greasy, oily or sticky drug substances
CN98811637A CN1280493A (zh) 1997-11-28 1998-11-18 用于油脂、油性或粘性药物的聚乙二醇基质颗粒状物
AT98957269T ATE286382T1 (de) 1997-11-28 1998-11-18 Polyethylenglycol-matrixpellets für fettige, ölige oder klebrige arzneistoffe
SK659-2000A SK6592000A3 (en) 1997-11-28 1998-11-18 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
IL13614498A IL136144A0 (en) 1997-11-28 1998-11-18 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
PCT/SE1998/002090 WO1999027913A1 (en) 1997-11-28 1998-11-18 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
JP2000522899A JP2001524514A (ja) 1997-11-28 1998-11-18 脂肪性、油性または粘着性薬剤物質のためのポリエチレングリコールマトリックスペレット
KR1020007005803A KR20010032558A (ko) 1997-11-28 1998-11-18 유지성, 유성 또는 점착성 약물을 위한 폴리에틸렌 글리콜매트릭스 펠렛
RU2000113730/14A RU2216316C2 (ru) 1997-11-28 1998-11-18 Гранулы с полиэтиленгликолевой матрицей для жирных, маслянистых или клейких лекарственных веществ
DE69828527T DE69828527T2 (de) 1997-11-28 1998-11-18 Polyethylenglycol-matrixpellets für fettige, ölige oder klebrige arzneistoffe
CA002311930A CA2311930A1 (en) 1997-11-28 1998-11-18 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
US09/214,317 US6555138B1 (en) 1997-11-28 1998-11-18 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
HU0004405A HUP0004405A3 (en) 1997-11-28 1998-11-18 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
AU13564/99A AU746324B2 (en) 1997-11-28 1998-11-19 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
NO20002720A NO20002720L (no) 1997-11-28 2000-05-26 Polyetylenglykolmatrisepellets for fettede, oljeaktige eller klebrige legemiddelsubstanser
US10/385,926 US20030175352A1 (en) 1997-11-28 2003-03-11 Matrix pellets for greasy, oily or sticky drug substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704401A SE9704401D0 (sv) 1997-11-28 1997-11-28 Matrix pellets for greasy, oily or sticky drug substances

Publications (1)

Publication Number Publication Date
SE9704401D0 true SE9704401D0 (sv) 1997-11-28

Family

ID=20409178

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704401A SE9704401D0 (sv) 1997-11-28 1997-11-28 Matrix pellets for greasy, oily or sticky drug substances

Country Status (23)

Country Link
US (2) US6555138B1 (sv)
EP (1) EP1032371B1 (sv)
JP (1) JP2001524514A (sv)
KR (1) KR20010032558A (sv)
CN (1) CN1280493A (sv)
AR (1) AR016684A1 (sv)
AT (1) ATE286382T1 (sv)
AU (1) AU746324B2 (sv)
BR (1) BR9814756A (sv)
CA (1) CA2311930A1 (sv)
DE (1) DE69828527T2 (sv)
HU (1) HUP0004405A3 (sv)
ID (1) ID24185A (sv)
IL (1) IL136144A0 (sv)
NO (1) NO20002720L (sv)
NZ (1) NZ504354A (sv)
PL (1) PL340926A1 (sv)
RU (1) RU2216316C2 (sv)
SE (1) SE9704401D0 (sv)
SK (1) SK6592000A3 (sv)
TW (1) TW570813B (sv)
WO (1) WO1999027913A1 (sv)
ZA (1) ZA9810465B (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
SE9704401D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
JP3887588B2 (ja) * 2002-08-30 2007-02-28 株式会社リガク Ｘ線回折による応力測定法
US8986737B2 (en) 2002-09-05 2015-03-24 Wm. Marsh Rice University Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
US20070059358A1 (en) * 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them
US20080014228A1 (en) * 2006-07-14 2008-01-17 Olivia Darmuzey Solid form
AU2007335156A1 (en) * 2006-12-20 2008-06-26 Mylan Pharmaceuticals Ulc Pharmaceutical composition comprising a hot-melt granulated lubricant
AU2014201170B2 (en) * 2006-12-20 2015-09-24 Mylan Pharmaceuticals Ulc Pharmaceutical composition comprising a hot-melt granulated lubricant
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
KR102340388B1 (ko) 2013-09-19 2021-12-17 마이크로벤션, 인코포레이티드 중합체 필름
EP3046952B1 (en) 2013-09-19 2021-05-12 Terumo Corporation Polymer particles
KR102287781B1 (ko) 2013-11-08 2021-08-06 테루모 가부시키가이샤 중합체 입자
CN104133014B (zh) * 2014-07-16 2015-09-16 广州法尔麦兰药物技术有限公司 一种考察布洛伪麻缓释制剂释放度的方法
US9907880B2 (en) 2015-03-26 2018-03-06 Microvention, Inc. Particles
KR102310696B1 (ko) 2016-09-28 2021-10-12 테루모 가부시키가이샤 색전 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE557670C (de) 1932-08-26 Friedrich Rittershausen Abtast- bzw. Bildzusammensetzvorrichtung
DE454386C (de) 1924-05-27 1928-01-06 Chemische Produkte Vormals H S Verfahren zur Herstellung pharmazeutischer und diaetetischer Praeparate in kugelaehnlicher Form
US2699054A (en) 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
DE2251197C3 (de) 1972-10-19 1980-05-08 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von hxxochdosierten Tabletten von Tetracyclin- Derivaten
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
ES2037179T3 (es) * 1987-11-25 1993-06-16 American Cyanamid Company Sistema de liberacion sostenida (controlada) para bloqueadores de canales de calcio de dihidropiridina.
DK0701815T3 (da) * 1992-01-17 2000-02-07 Alfatec Pharma Gmbh Fremgangsmåde til fremstilling af aktivstofholdige pulvere, granulater eller pellets med en grundstruktur af hydrofile makr
US5876754A (en) * 1992-01-17 1999-03-02 Alfatec-Pharma Gmbh Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
ATE179606T1 (de) * 1992-02-25 1999-05-15 Spirig Ag Minocyclin enthaltende pellets
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
SE9704401D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances

Also Published As

Publication number Publication date
PL340926A1 (en) 2001-03-12
BR9814756A (pt) 2000-10-03
CA2311930A1 (en) 1999-06-10
NZ504354A (en) 2001-12-21
SK6592000A3 (en) 2001-01-18
JP2001524514A (ja) 2001-12-04
DE69828527T2 (de) 2005-12-29
EP1032371B1 (en) 2005-01-05
AR016684A1 (es) 2001-07-25
RU2216316C2 (ru) 2003-11-20
HUP0004405A2 (hu) 2001-08-28
AU746324B2 (en) 2002-04-18
ZA9810465B (en) 1999-05-21
CN1280493A (zh) 2001-01-17
WO1999027913A1 (en) 1999-06-10
AU1356499A (en) 1999-06-16
US20030175352A1 (en) 2003-09-18
ID24185A (id) 2000-07-13
US6555138B1 (en) 2003-04-29
IL136144A0 (en) 2001-05-20
EP1032371A1 (en) 2000-09-06
HUP0004405A3 (en) 2004-03-29
NO20002720L (no) 2000-07-28
TW570813B (en) 2004-01-11
ATE286382T1 (de) 2005-01-15
NO20002720D0 (no) 2000-05-26
KR20010032558A (ko) 2001-04-25
DE69828527D1 (de) 2005-02-10

Similar Documents

Publication Publication Date Title
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
ATE464885T1 (de) Verfahern zur herstellung von festen verabreichungssystemen für eingekapselte und nicht-eingekapselte pharmazeutische wirkstoffe
DK0939626T3 (da) Galenisk form til forlænget frigivelse af milnacipran
WO2003103637A3 (en) MODIFIED RELEASE MULTIPLE UNIT DRUG DELIVERY SYSTEMS
AR002754A1 (es) Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento
ATE417604T1 (de) Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
BR9405798A (pt) Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
MY100721A (en) Therapeutic agent.
NO20024919D0 (no) Hydrofil/lipofil polymer matriksdoseringsformulering
EP1287822A3 (en) Mesalazine controlled release oral pharmaceutical compositions
ATE108647T1 (de) Arzneimittel mit langsamer wirkstofffreisetzung.
FI94094B (sv) Bärarkomposition för läkemedelspreparat med fördröjd verkan
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
SE8803822D0 (sv) Novel dosage form
WO2001013898A3 (en) Pharmaceutical formulations with different release times
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
CA2487968A1 (en) A novel drug dosing regimen
ES2169980A1 (es) Microcapsulas para la liberacion prolongada de farmacos.
CA2209673A1 (en) Solid medicament form with active agent distributed in polymer material
DE60121925D1 (de) Arzneimittel zur verabreichung an schleimhäute
BR9710629A (pt) Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto